All nirmatrelvir articles
-
NewsVaccinated people had lower risk of severe COVID-19 outcomes
Among people who had COVID-19, those who previously received the latest vaccine had a lower risk of having a severe outcome than those who had not, according to new research.
-
NewsHIV drug could prevent coronaviruses, study finds
New research has shown how an HIV drug could stop many coronavirus diseases, including the SARS-CoV-2 variants, when given to infected cells at the right concentration.
-
NewsMolnupiravir dose of human effect size-equivalent blocks Covid transmission in ferrets
Two oral drugs provide equivalent therapeutic benefit in preventing severe COVID-19 in animal models, but only molnupiravir efficiently blocked SARS-CoV-2 transmission when administered at a human effect size-equivalent dose.
-
NewsStudy finds evidence of resistance to COVID-19 drugs
Resistance to Paxlovid is already evident among viral SARS-CoV-2 variants currently circulating globally, indicating that this stand-alone drug known as a protease inhibitor could soon become less effective in treating COVID-19 infections, a new study suggests.
